Neuroprotection in Hypoxic-Ischemic Brain Injury Targeting Glial Cells

Curr Pharm Des. 2017;23(26):3899-3906. doi: 10.2174/1381612823666170727145422.

Abstract

Brain injury constitutes a disabling health condition of several etiologies. One of the major causes of brain injury is hypoxia-ischemia. Until recently, pharmacological treatments were solely focused on neurons. In the last decades, glial cells started to be considered as alternative targets for neuroprotection. Novel treatments for hypoxia-ischemia intend to modulate reactive forms of glial cells, and/or potentiate their recovery response. In this review, we summarize these neuroprotective strategies in hypoxia-ischemia and discuss their mechanisms of action.

Keywords: brain injury; glial cells; hypoxia-ischemia; neuroprotection; pharmacological treatments.

Publication types

  • Review

MeSH terms

  • Animals
  • Drug Delivery Systems / trends*
  • Humans
  • Hypoxia-Ischemia, Brain / drug therapy
  • Hypoxia-Ischemia, Brain / metabolism*
  • Hypoxia-Ischemia, Brain / pathology
  • Neuroglia / drug effects
  • Neuroglia / metabolism*
  • Neuroglia / pathology
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / pathology
  • Neuroprotection / drug effects
  • Neuroprotection / physiology*
  • Neuroprotective Agents / administration & dosage*
  • Neuroprotective Agents / metabolism

Substances

  • Neuroprotective Agents